Evidence Explorer · MS-N270 · Supportive physical care · Appraised November 8, 2026
One prospective randomized study reported fewer cases of lower-limb lymphedema with 23–32 mmHg stockings plus education and activity guidance after gynecologic-cancer treatment. The result is promising, but the 2026 systematic review found only one qualifying randomized trial.
Evidence at a glance
- Population: 64 women treated for gynecologic malignancies.
- Intervention: medium-pressure stockings (23–32 mmHg) plus standard education and physical-activity guidance for 12 months.
- Comparator: the same education and activity guidance without stockings.
- Primary result: lower-limb lymphedema occurred in 3.4% with stockings and 38% without them (P=.003).
- Evidence label: promising single-trial preventive evidence; replication needed.
What was studied
The study followed limb volume, symptoms and quality of life for 12 months. Comfort and adherence were reported as good, but accessible reporting did not verify all fitting, dropout and adverse-event details.
A 2026 systematic review concluded that the evidence base still consisted of this single randomized trial. The large absolute difference should therefore be interpreted as an estimate needing independent replication rather than a settled universal policy.
What this evidence cannot establish
The finding applies to a defined postoperative gynecologic-cancer population using class II stockings alongside education and activity. It does not establish the best pressure, duration or strategy for people with arterial disease, established swelling, different cancer surgery or radiotherapy exposure.
Safety and practical context
Compression can worsen ischemia or cause pressure injury, numbness and skin breakdown when fit is wrong. Assessment is especially important with peripheral arterial disease, neuropathy, wounds, infection or marked limb-shape change. Sudden unilateral swelling needs evaluation for thrombosis or obstruction.
Questions for the care team
- What is my baseline lymphedema risk and how will it be measured?
- Is 23–32 mmHg appropriate for my circulation, sensation and skin?
- Who will refit or stop the garment if swelling, pain, numbness or skin changes occur?
Sources and identifiers
- Prospective randomized study — PMID 40805226
- 2026 systematic review — PMID 42526142
Funding and conflicts: Funding and conflict details were not fully verified from the accessible source summaries.
Source access and dates: Original PubMed records and available full texts were checked November 8, 2026. Last literature search November 8, 2026.
Educational evidence summary, not individualized medical advice. Supportive-care outcomes do not demonstrate tumor response, recurrence prevention or longer survival.
